Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod in Chinese Patients With Relapsing-remitting Multiple Sclerosis
NCT01941004Phase 3Withdrawn
- Sponsor
- Novartis
- Start
- Jun 2014
- Primary completion
- May 2017
01
Overview
A Phase 3 trial of fingolimod in multiple sclerosis (MS), sponsored by Novartis. Planned start Jun 2014; status: withdrawn.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01941004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941004.